3Dumitriu IE, Dunbar DR, Howie SE, Sethi T, Gregory CD. Human dendritic cells produce TGF-beta l under the influ- ence of lung carcinoma cells and prime the differentiation of CD4+CD256Foxp3+ regulatory T cells. J lmmunol 2009; 182(5): 2795-807.
4Idoyaga J, Moreno J, Bonifaz L. Tumor cells prevent mouse den- dritic cell maturation induced by TLR ligands. Cancer Immunol lmmunother 2007; 56(8): 1237-50.
5Dummer R, Urosevic M, Kempf W, Hoek K, Hafner J, Burg G. lmiquimod in basal cell carcinoma: How does it work? Br J Der- matol 2003; 149 Suppl 66: 57-8.
6Shen L, Evel-Kabier K, Strube R, Chen SY. Silencing of SOCSI enhances antigen presentation by dendritic cells and antigen-specif- ic anti-tumor immunity. Nat Biotechnol 2004; 22(12): 1546-53.
7Herber DL, Can W, Nefedova Y, Novitskiy SV, Nagaraj S, Tyurin VA, et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nat Med 2010; 16(8): 880-6.
8Zitvogel L, Kroemer G. Targeting dendritic cell metabolism in cancer. Nat Med 2010; 16(8): 858-9.
9Scarlett UK, Rutkowski MR, Rauwerdink AM, Fields J, Escovar- Fadul X, Baird J, et al. Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. J Exp Med 2012; 209(3): 495-506.
二级参考文献1
1Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, et al. CCL2 recruits inflammatory monocytes to facilitate breast- tumour metastasis. Nature 201 l; doi: 10.1038/nature10138.
3HANAHAN D, WEINBERG R A. Hallmarks of cancer: the next generation [ J ]. Cell,2011,144 (5) :646-674.
4BALACHANDRAN V P, CAVNAR M J, ZENG S, et al. Imatinib potentiates antitumor T cell responses in gastro- intestinal stromal tumor through the inhibition of Ido [ J ]. Nat Med,2011,17(9) :1094-1100.
5ZITVOGEL L, KEPP O, KROEMER G. Immune parame- ters affecting the efficacy of chemotherapeutic regimens [J]. Nat Rev Clin Oncol,2011,8(3) :151-160.
6ANTONY P A, RESTIFO N P. CD4 CD25 T regulatory cells, immunotherapy of cancer, and interleukin-2 [ J ]. J Immunother, 2005,28 (2) : 120 -128.
7GAI X D, LI C, SONG Y, et al. In situ analysis of FOXP3 + regulatory T ceils and myeloid dendritic ceils in hu- man colorectal cancer tissue and tumor-draining lymph node[ J]. Biomed Rep,2013,1 (2) :207-212.
8TANG Y, XU X, GUO S, et al. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarci- noma[ J]. PLoS One,2014,9(3 ) :e91551.
9ZOU W. Regulatory T cells, tumour immunity and immu- notherapy[ J]. Nat Rev Immunol,2006,6(4):295-307.
10WHITESIDE T L. Regulatory T cell subsets in human cancer: are they regulating for or against tumor progres- sion? [ J ] Cancer Immunol Immunother, 2014,63 ( 1 ) : 67-72.